Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | -14,662 | 1,859 | 3,205 |
| Gross Profit | N/A | N/A | -14,662 | 1,859 | 3,205 |
| Operating Expenses | 17,919 | 14,843 | 11,147 | 9,657 | 10,480 |
| Operating Income | -17,919 | -14,843 | -25,809 | -7,798 | -7,275 |
| Other Income | 941 | 15,872 | -1,005 | -6,168 | 1,468 |
| Pre-tax Income | -16,978 | 1,029 | -26,814 | -13,966 | -5,807 |
| Income Tax | N/A | N/A | 253 | 65 | N/A |
| Net Income Continuous | -16,978 | 1,029 | -27,067 | -14,031 | -5,807 |
| Net Income | $-16,978 | $1,029 | $-27,067 | $-14,031 | $-5,807 |
| EPS Basic Total Ops | -1.42 | 1.03 | -76.91 | -40.52 | -16.69 |
| EPS Basic Continuous Ops | -1.42 | 1.03 | -76.91 | -40.52 | -16.69 |
| EPS Diluted Total Ops | -1.42 | -6.33 | -76.91 | -40.52 | -16.69 |
| EPS Diluted Continuous Ops | -1.42 | 0.44 | -76.91 | -40.52 | -16.69 |
| EPS Diluted Before Non-Recurring Items | -1.42 | -13.15 | -4.32 | N/A | N/A |
| EBITDA(a) | $-17,938 | $-14,691 | $-25,655 | $-7,667 | $-7,126 |